Joseph Douglas Lyon, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 396,250 shares at $114.53 ($39.8M) on 2025-04-01, disclosed to the SEC on 2025-04-02.
Scheduled sale ($39.8M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.22 | 162,008 | $16.2M | 40.8% |
| 2 | $100.22 | 162,008 | $16.2M | 40.8% |
| 3 | $101.37 | 32,942 | $3.3M | 8.4% |
| 4 | $101.37 | 32,942 | $3.3M | 8.4% |
| 5 | $102.48 | 5,050 | $518K | 1.3% |
| 6 | $114.53 | 650 |
| $74K |
| 0.2% |
| 7 | $114.53 | 650 | $74K | 0.2% |
| Total | $100.49 avg | 396,250 | $39.8M | 100% |
| Filing → |
| CORT | SELL | 2026-08-05 | $176K | — | Filing → |
| CORT | SELL | 2026-05-29 | $325K | — | Filing → |
| CORT | SELL | 2025-12-03 | $398K | — | Filing → |